MedPath

The Influencing Factors of Vancomycin Trough Level and the Rate Achieving the Target Trough Level

Completed
Conditions
Vancomycin
Registration Number
NCT03806543
Lead Sponsor
Southeast University, China
Brief Summary

The aim of this study was to assess factors that may influence vancomycin trough level and the rate achieving the target trough level in critically ill patients.

Detailed Description

This retrospective observational study included adult patients treated with intravenous vancomycin in intensive care unit of Zhongda Hospital from January 2015 to December 2017. Vancomycin dose was based on international consensus and adjusted according to estimated glomerular filtration rate (eGFR) calculated by the Cockcroft-Gault equation. vancomycin trough level (VTL) was retained at steady state (after the third dose). Linear regression was performed to determine the correlation between factors prior to the first vancomycin dose and VTL. Distribution of VTL and percentage of patients achieving the target trough level (15-20mg/L) was observed in different renal function.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
165
Inclusion Criteria
  • Adult ICU patients (age≥18 years) treated with intravenous vancomycin were included
Exclusion Criteria
  • Chronic renal dysfunction and acute renal injury patients treated with Renal Replacement therapy
  • VTL was not retained at steady-state
  • Vancomycin treatment time≤48h
  • Vancomycin dose did not meet study definitions
  • Palliative care

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of patients achieving the target vancomycin trough(15-20mg/L)3 years

Vancomycin trough level was retained at steady state (after the third dose). If a patient has multiple measurements of vancomycin trough level, the first measurement is collected.Rate of patients achieving the target trough level (15-20mg/L) was observed.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath